Profile

Culture

Core team

Qualification

Technology

Cooperation

Clinical testing service: Tumor personalized liquid biopsy Lung cancer detection Gastric and colorectal cancer treatment target detection Female gynecological oncology Pan-cancerous solid tumor (multi-cancer) Chemotherapy guidance Hereditary tumor detection; Tumor personalized clinical testing Lung cancer detection Gastric and colorectal cancer treatment target detection Female gynecological oncology Immunity therapy Pan-cancerous solid tumor (multi-cancer) Chemotherapy guidance Hereditary tumor detection

Health checkup products: Rui Health; Ryan

Cutting-edge research services: Single cell sequencing; T cell immune library sequencing; New antigen detection; Tumor personalized science research; High-throughput multi-omics sequencing and analysis services

News

Knowledge

Recruitment

Staff style

APP download

WeChat

Tel: +86-571-89360709 E-mail: service@repugene.com
Address: 21-23, Health Valley, No. 1500, Wenyi West Road, Yuhang District, Hangzhou, Zhejiang, China
Copyright: Hangzhou Repugene Technology Co., Ltd. Powered by www.300.cn
浙ICP备16003170号

Hangzhou Repugene Technology Co., Ltd. is a high-tech advanced biomedical research and development enterprise with the team of Dr. Haigui.

core team

Ms. Lou Shengqiong

Release time：

2019/01/19 17:19

Page view

[Abstract]:

Founder of the company, general manager of Rip Gene;
US MBA;
Vice President of Zhejiang Women Entrepreneurs Association;
Executive President of Hangzhou Women Entrepreneurs Association;
Senior investment manager;
Successfully established and managed the Great Wall International Restaurant Chain Group;
Invested in a number of domestic enterprises, covering biomedicine, information security and other fields, its investment in Beida Pharmaceuticals was successfully listed on the Shenzhen GEM in 2016.

Founder of the company, general manager of Rip Gene;

US MBA;

Vice President of Zhejiang Women Entrepreneurs Association;

Executive President of Hangzhou Women Entrepreneurs Association;

Senior investment manager;

Successfully established and managed the Great Wall International Restaurant Chain Group;

Invested in a number of domestic enterprises, covering biomedicine, information security and other fields, its investment in Beida Pharmaceuticals was successfully listed on the Shenzhen GEM in 2016.

Dr. Ding Liming